{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:32:55Z","timestamp":1791343975195,"version":"4.3.1"},"reference-count":44,"publisher":"Japanese Society of Hypertension","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1291\/hypres.30.535","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T05:50:40Z","timestamp":1185947440000},"page":"535-540","source":"Crossref","is-referenced-by-count":30,"title":["Prevalence of Paroxysmal Atrial Fibrillation Depending on the Regression of Left Ventricular Hypertrophy in Arterial Hypertension"],"prefix":"10.1291","volume":"30","author":[{"given":"Marcus G.","family":"HENNERSDORF","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per O.","family":"SCHUELLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"STEINER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo E.","family":"STRAUER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Evers S, Hennersdorf M, Perings C, Strauer BE: The epidemiology and causes of atrial fibrillation. <i>Herzschr Electrophysiol<\/i> 2001; <b>12<\/b>: 59-67.","DOI":"10.1007\/s003990170025"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90208-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lip GYH, Hee LS: Paroxysmal atrial fibrillation. <i>Q J Med<\/i> 2001; <b>94<\/b>: 665-678.","DOI":"10.1093\/qjmed\/94.12.665"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.271.11.840"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Petersen P, Godfresen J: Embolic complications in paroxysmal atrial fibrillation. <i>Stroke<\/i> 1984; <b>17<\/b>: 622-625.","DOI":"10.1161\/01.STR.17.4.622"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hennersdorf MG, Perings C, Kelm M, Strauer BE: Atrial fibrillation. <i>Internist<\/i> (<i>Berl<\/i>) 2001; <b>42<\/b>: 1631-1640.","DOI":"10.1007\/s001080170015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C, on behalf of the TRACE Study Group: Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. <i>Circulation<\/i> 1999; <b>100<\/b>: 376-380.","DOI":"10.1161\/01.CIR.100.4.376"},{"issue":"2","key":"8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.HYP.36.2.220","volume":"36","author":"SCHWARTZKOPFF B","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.275.19.1507"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00158-X"},{"key":"11","unstructured":"11. Vogt M, Kreutz KU, Motz W, Strauer BE: Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function. <i>Z Kardiol<\/i> 1989; <b>78<\/b>: 469-477."},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00399-5"},{"issue":"5","key":"13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.27.5.1031","volume":"27","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Strauer BE, Schwartzkopff B, Kelm M: Assessing the coronary circulation in hypertension. <i>J Hypertens<\/i> 1998; <b>16<\/b>: 1221-1233.","DOI":"10.1097\/00004872-199816090-00001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gottdiener JS, Reda DJ, Williams DW, Materson BJ, Cushman W, Anderson WJ, for the VA Cooperative Group on Antihypertensive Agents: Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension. <i>Circulation<\/i> 1998; <b>98<\/b>: 140-148.","DOI":"10.1161\/01.CIR.98.2.140"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.068"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. <i>Circulation<\/i> 1977; <b>55<\/b>: 613-618.","DOI":"10.1161\/01.CIR.55.4.613"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left-ventricular mass and geometry to morbidity and mortality in uncomplicated essential-hypertension. <i>Ann Intern Med<\/i> 1991; <b>114<\/b>: 345-352.","DOI":"10.7326\/0003-4819-114-5-345"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fuster V, Ryden LE, Cannom DS, <i>et al<\/i>: ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). <i>Eur Heart J<\/i> 2006; <b>27<\/b>: 1979-2030.","DOI":"10.1093\/eurheartj\/ehm315"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Messerli FH, Nunez BD, Nunez MM, Garavaglia GE, Schmieder RE, Ventura HO: Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. <i>Arch Intern Med<\/i> 1989; <b>149<\/b>: 1263-1267.","DOI":"10.1001\/archinte.149.6.1263"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Schannwell CM, Schoebel FC, Badiian M, <i>et al<\/i>: Diastolic function parameters and atrial arrhythmias in patients with arterial hypertension. <i>Dtsch Med Wochenschr<\/i> 1998; <b>123<\/b>: 957-964.","DOI":"10.1055\/s-2007-1024104"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000052830.02773.E4"},{"key":"23","unstructured":"23. Strauer BE: Hypertensive Heart Disease, 3rd ed. Berlin, Heidelberg, New York, and Tokyo, Springer, 1991."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Strauer BE: The significance of coronary reserve in clinical heart disease. <i>J Am Coll Cardiol<\/i> 1990; <b>15<\/b>: 775-783.","DOI":"10.1016\/0735-1097(90)90273-R"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kelm M, Strauer BE: Coronary flow reserve measurements in hypertension. <i>Med Clin North Am<\/i> 2004; <b>88<\/b>: 99-113.","DOI":"10.1016\/S0025-7125(03)00119-6"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(79)90235-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. <i>Circulation<\/i> 1993; <b>88<\/b>: 993-1003.","DOI":"10.1161\/01.CIR.88.3.993"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Assayag P, Carr&eacute; F, Chevalier B, Delcayre C, Mansier P, Swynghedauw B: Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. fibrosis. <i>Cardiovasc Res<\/i> 1997; <b>34<\/b>: 439-444.","DOI":"10.1016\/S0008-6363(97)00073-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hennersdorf MG, Hafke G, Steiner S, <i>et al<\/i>: Determinants of paroxysmal atrial fibrillation in patients with aterial hypertension. <i>Z Kardiol<\/i> 2003; <b>92<\/b>: 370-376.","DOI":"10.1007\/s00392-003-0924-5"},{"key":"30","unstructured":"30. Frohlich ED: Clinical-physiologic classification of hypertensive heart disease in essential hypertension. in Moyer JH (ed): Hypertension: Mechanisms and Management, 3rd ed. New York, Grune &#38; Stratton, 1973, pp 181-190."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Gerdts E, Oikarinen L, Palmieri V, <i>et al<\/i>: Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy. <i>Hypertension<\/i> 2002; <b>39<\/b>: 739-743.","DOI":"10.1161\/hy0302.105683"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Dittrich HC, Pearce LA, Asinger RW, <i>et al<\/i>, on behalf of the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators: Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. <i>Am Heart J<\/i> 1999; <b>137<\/b>: 494-499.","DOI":"10.1016\/S0002-8703(99)70498-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Aronow WS, Ahn C, Kronzon I, Gutstein H: Association of left ventricular hypertrophy and chronic atrial fibrillation with the incidence of new thromboembolic stroke in 2,384 older persons. <i>Am J Cardiol<\/i> 1999; <b>84<\/b>: 468-469.","DOI":"10.1016\/S0002-9149(99)00336-7"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Devereux RB, Palmieri V, Liu JE, <i>et al<\/i>: Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention for Endpoint Reduction study. <i>J Hypertens<\/i> 2002; <b>20<\/b>: 1445-1450.","DOI":"10.1097\/00004872-200207000-00033"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Manolis AJ, Beldekos D, Handanis S, <i>et al<\/i>: Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy. Effects on LVH regression and arrhythmogenic propensity. <i>Am J Hypertens<\/i> 1998; <b>11<\/b>: 640-648.","DOI":"10.1016\/S0895-7061(98)00036-3"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199611000-00015"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.173"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Goette A, Arndt M, Rocken C, <i>et al<\/i>: Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. <i>Circulation<\/i> 2000; <b>101<\/b>: 2678-2681.","DOI":"10.1161\/01.CIR.101.23.2678"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.79"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.277"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000022665.18619.83"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.08.014"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Schuchert A, Behrens G, Meinertz T: Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. <i>Pacing Clin Electrophysiol<\/i> 1999; <b>22<\/b>: 1082-1084.","DOI":"10.1111\/j.1540-8159.1999.tb00574.x"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T16:48:38Z","timestamp":1683996518000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.30.535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.30.535","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}